Analysis of Telix Pharmaceuticals, Bank of Queensland, MAAS Group Holdings
Fund Manager Chris Pedersen discusses Telix Pharmaceuticals, Bank of Queensland and MAAS Group Holdings.
Read More
Telix Pharmaceuticals Limited
Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR).
Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, and the United States. Telix is developing a portfolio of clinical-stage oncology products that address significant unmet medical need in prostate, renal and brain cancer. Telix is listed on the Australian Securities Exchange (ASX: TLX).
Spotlight Videos
Analysis of Telix Pharmaceuticals, Bank of Queensland, MAAS Group Holdings
Fund Manager Chris Pedersen discusses Telix Pharmaceuticals, Bank of Queensland and MAAS Group Holdings.
WATCH VIDEOAll Telix Pharmaceuticals Limited Content
News
Telix Pharmaceuticals (ASX: TLX) – Webinar Presentation
Dr Christian Behrenbruch - CEO & Managing Director - Telix is a late-stage radiopharmaceutical company developing diagnostic and therapeutic assets using Molecularly Targeted Radiation.
Read More
TELIX Pharmaceuticals – ShareCafe Hidden Gems Webinar Presentation
Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, and the United States.
Read More
